Jafron Biomedical Co.,Ltd. (SHE:300529)
China
· Delayed Price · Currency is CNY 19.06
-0.17 (-0.88%)
Apr 29, 2026, 3:04 PM CST
Jafron Biomedical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Cash & Equivalents | 470.23 | 2,516 | 1,725 | 2,810 | 2,559 | 2,319 | Upgrade
|
| Trading Asset Securities | 2,162 | 0.06 | 593.07 | - | - | 150.01 | Upgrade
|
| Cash & Short-Term Investments | 2,632 | 2,516 | 2,318 | 2,810 | 2,559 | 2,469 | Upgrade
|
| Cash Growth | 1.73% | 8.55% | -17.52% | 9.83% | 3.62% | 56.79% | Upgrade
|
| Accounts Receivable | 66.15 | 40.3 | 55.61 | 81.21 | 239.64 | 308.06 | Upgrade
|
| Other Receivables | 4.03 | 1.95 | 3.66 | 6.51 | 6.85 | 6.32 | Upgrade
|
| Receivables | 70.18 | 42.25 | 59.27 | 87.72 | 246.49 | 314.37 | Upgrade
|
| Inventory | 256.98 | 291.75 | 337.79 | 385 | 349.13 | 196.55 | Upgrade
|
| Prepaid Expenses | - | 0.69 | - | 0.32 | 14.55 | - | Upgrade
|
| Other Current Assets | 75.46 | 67.37 | 68.81 | 28.5 | 124.32 | 75.27 | Upgrade
|
| Total Current Assets | 3,034 | 2,918 | 2,784 | 3,312 | 3,293 | 3,056 | Upgrade
|
| Property, Plant & Equipment | 1,890 | 1,881 | 1,894 | 1,771 | 1,672 | 1,272 | Upgrade
|
| Long-Term Investments | 125.66 | 308.47 | 446.13 | 116.13 | 69.45 | 111.2 | Upgrade
|
| Goodwill | 7.01 | 7.01 | 7.01 | 12.21 | 37.81 | 44.07 | Upgrade
|
| Other Intangible Assets | 99.76 | 100.66 | 97.75 | 100.37 | 100.43 | 101.31 | Upgrade
|
| Long-Term Deferred Tax Assets | 42.32 | 41.81 | 34.97 | 30.35 | 36.49 | 26.54 | Upgrade
|
| Long-Term Deferred Charges | 82.4 | 86.65 | 87.19 | 94.87 | 59 | 35.95 | Upgrade
|
| Other Long-Term Assets | 239.42 | 64.95 | 32.35 | 107.03 | 148.22 | 162.91 | Upgrade
|
| Total Assets | 5,521 | 5,409 | 5,383 | 5,543 | 5,417 | 4,810 | Upgrade
|
| Accounts Payable | 94.13 | 112.27 | 119.19 | 135.62 | 128.52 | 60.76 | Upgrade
|
| Accrued Expenses | 75.95 | 117.16 | 125.07 | 158.21 | 157.48 | 192.98 | Upgrade
|
| Short-Term Debt | 2.16 | 39.39 | 77.51 | 261.83 | 317.09 | - | Upgrade
|
| Current Portion of Long-Term Debt | 9.74 | 7.02 | 192.2 | 16.79 | - | - | Upgrade
|
| Current Portion of Leases | - | 1.58 | 1.83 | 3.83 | 4.73 | 3.17 | Upgrade
|
| Current Income Taxes Payable | 83.57 | 34.37 | 56.63 | 30.52 | 2.55 | 23.19 | Upgrade
|
| Current Unearned Revenue | 29.33 | 30.76 | 16.86 | 37.57 | 42.3 | 20.65 | Upgrade
|
| Other Current Liabilities | 53.69 | 159.54 | 177.51 | 185.03 | 64.52 | 85.51 | Upgrade
|
| Total Current Liabilities | 348.56 | 502.1 | 766.79 | 829.42 | 717.18 | 386.26 | Upgrade
|
| Long-Term Debt | 1,225 | 1,183 | 1,110 | 1,381 | 936.78 | 897.37 | Upgrade
|
| Long-Term Leases | 4.14 | 4.09 | 4.74 | 11.35 | 17.34 | 17.01 | Upgrade
|
| Long-Term Unearned Revenue | 223.19 | 228.64 | 144.95 | 151.78 | 151.66 | 125.08 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 17.5 | 16.4 | 16.11 | 16.78 | 3.12 | 0.73 | Upgrade
|
| Other Long-Term Liabilities | 2.96 | 3.02 | 6 | - | - | - | Upgrade
|
| Total Liabilities | 1,822 | 1,938 | 2,049 | 2,390 | 1,826 | 1,426 | Upgrade
|
| Common Stock | 798.61 | 798.61 | 798.61 | 807.56 | 807.71 | 805.5 | Upgrade
|
| Additional Paid-In Capital | 226.67 | 219.17 | 231.26 | 694.14 | 678.04 | 618 | Upgrade
|
| Retained Earnings | 3,052 | 2,832 | 2,918 | 2,408 | 2,507 | 2,336 | Upgrade
|
| Treasury Stock | -500.02 | -500.06 | -733.82 | -880.63 | -509.69 | -523.8 | Upgrade
|
| Comprehensive Income & Other | 122.49 | 122.49 | 119.69 | 118.63 | 91.7 | 123.14 | Upgrade
|
| Total Common Equity | 3,700 | 3,472 | 3,334 | 3,147 | 3,574 | 3,359 | Upgrade
|
| Minority Interest | -0.26 | -0.39 | 0.76 | 5.4 | 16.17 | 24.79 | Upgrade
|
| Shareholders' Equity | 3,700 | 3,471 | 3,335 | 3,153 | 3,590 | 3,384 | Upgrade
|
| Total Liabilities & Equity | 5,521 | 5,409 | 5,383 | 5,543 | 5,417 | 4,810 | Upgrade
|
| Total Debt | 1,241 | 1,235 | 1,386 | 1,675 | 1,276 | 917.55 | Upgrade
|
| Net Cash (Debt) | 1,390 | 1,280 | 931.31 | 1,135 | 1,283 | 1,552 | Upgrade
|
| Net Cash Growth | 18.03% | 37.49% | -17.97% | -11.49% | -17.34% | -1.47% | Upgrade
|
| Net Cash Per Share | 1.82 | 1.66 | 1.19 | 1.43 | 1.62 | 1.93 | Upgrade
|
| Filing Date Shares Outstanding | 787.55 | 774.36 | 774.36 | 774.47 | 798.87 | 815.46 | Upgrade
|
| Total Common Shares Outstanding | 787.55 | 774.36 | 774.36 | 774.47 | 798.86 | 815.46 | Upgrade
|
| Working Capital | 2,686 | 2,416 | 2,017 | 2,482 | 2,576 | 2,669 | Upgrade
|
| Book Value Per Share | 4.70 | 4.48 | 4.31 | 4.06 | 4.47 | 4.12 | Upgrade
|
| Tangible Book Value | 3,593 | 3,364 | 3,229 | 3,035 | 3,436 | 3,213 | Upgrade
|
| Tangible Book Value Per Share | 4.56 | 4.34 | 4.17 | 3.92 | 4.30 | 3.94 | Upgrade
|
| Buildings | - | 1,297 | 1,296 | 1,260 | 890.61 | 812.74 | Upgrade
|
| Machinery | - | 823.61 | 764.58 | 678.23 | 514.6 | 304.98 | Upgrade
|
| Construction In Progress | - | 272.97 | 244.45 | 122.43 | 473.99 | 301.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.